News

The anticonvulsant fosphenytoin is safe and effective in quickly decreasing pain from sudden attacks of acute trigeminal ...
The May 2025 issue of NEJM Catalyst Innovations in Care Delivery highlights programs and interventions at many different health care organizations to address the ills of patients and care delivery ...
Luminis Health activated its Incident Command system and rapidly developed and implemented a comprehensive intravenous fluid ...
Adding intravenous thrombolysis to endovascular treatment is not associated with an increased risk for bleeding or with changes in functional outcomes in patients with carotid tandem lesions.
A multidisciplinary clinical team led by Professor Bernat Soria from the Institute of Bioengineering at the Miguel Hernández ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...
Over five years, relapsing-remitting multiple sclerosis patients in France taking Tysabri have adopted more at-home dosing, a review found.
Subcutaneous Opdivo showed comparable effectiveness, safety and tolerability to IV Opdivo in advanced clear cell renal cell ...
The following is a summary of "Incidence of Clinically Significant Ventricular Arrhythmias in Patients on Home Inotrope Infusion in the Contemporary Era," published in the March 2025 issue of American ...